Skip to main content
. 2017 Sep 8;8(61):103129–103136. doi: 10.18632/oncotarget.20789

Figure 2. Treatment protocol for ES PDOX.

Figure 2

G1: untreated control; G2: combination treatment with GEM + DOC (GEM: intraperitoneal [i.p.], 100 mg/kg, weekly, 2 weeks, DOC: i.p., 20 mg/kg, weekly, 2 weeks); G3: combination treatment with IRT + TEM (IRT: i.p., 4 mg/kg, daily, 2 weeks, TEM: oral [p.o.], 25 mg/kg, daily, 2 weeks); G4: PAZ (p.o., 100 mg/kg, daily, 2 weeks); G5: YON (intravenous [i.v.], 0.15 mg/kg, weekly, 2 weeks). Each group consisted of n=6 mice. All mice were sacrificed on day 15. GEM=gemcitabine; DOC=docetaxel; IRT=irinotecan; TEM=temozolomide.